Friday, July 10, 2026

Drug profile · INN

andexanet alfa

andexanet alfa (ONDEXXYA) is a tissue factor pathway inhibitor inhibitor.

EMA: approved Various (V03) V03AB
Patents linked 0
Pipeline programs 2
News articles 0
Drug details — andexanet alfa
Class
Various (V03)
Route
Patents
0
Programs
2
Data quality
0.83

Quick answer

andexanet alfa (ONDEXXYA) is a tissue factor pathway inhibitor inhibitor.

Key facts

INN andexanet alfa
Brand ONDEXXYA
Mechanism Tissue factor pathway inhibitor inhibitor
Target Apixaban
Therapeutic class Various (V03)
ATC code V03AB

Mechanism of action

Tissue factor pathway inhibitor inhibitor

Primary target: Apixaban

Approval history

Authority Status Date
EMA approved

Pipeline programs

  1. D9604C00001 Phase 3 · AstraZeneca · Reversal of anticoagulation effect in patients on a FXa inhi
  2. D9609C00001 Phase 1 · AstraZeneca · Healthy Volunteers

Related & competitor drugs

  1. besilesomab Various (V09)
  2. deferasirox Various (V03)
  3. ferric citrate coordination complex Various (V03)
  4. folic acid Various (V04)
  5. sevelamer carbonate Various (V03)
  6. sugammadex sodium Various (V03)

Frequently asked questions

What is andexanet alfa?

andexanet alfa (ONDEXXYA) is a tissue factor pathway inhibitor inhibitor.

What is the brand name for andexanet alfa?

ONDEXXYA is a marketed brand name for andexanet alfa. Check FDA Drugs@FDA for the current US label holder and prescribing information.